首页> 外国专利> Sulfonamidsubstituerte kromaner, fremgangsmÕte for fremstilling derav, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene

Sulfonamidsubstituerte kromaner, fremgangsmÕte for fremstilling derav, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene

机译:磺酰胺取代的苯并二氢吡喃,其制备方法,其在含有该化合物的药物和药物制剂中的用途

摘要

Compounds of the formula in whic: R(1) and R(2) independently of one another are hydrogen, CF3, C2F5, C3F7, alkyl having 1 to 6 carbon atoms, or phenyl, which is substituted or unsubstituted by 1 or 2 substituents, selected from the group consisting of F, Cl, Br, I, CF3, NO2, CN, NH2, OH, methyl, ethyl, methoxy, 2138 ה' בחשון התשס" ד - October 31, 2003 dimethylamino, sulfamoyl, methylsulfonyl and methylsulfonylamino; or R(1) and R(2) together are an alkylene chain having 2, 3, 4, 5, 6, 7, 8, 9 or 10 carbon atoms; R(3) is R(10)-CnH2n-NR(11)- or R(10)-CnH2n-, where one CH2 group in the groups CnH2n can be replaced by -O-, -CO-, -S-, -SO-, -SO2- or -NR(12a)-; R(12a) is hydrogen, methyl or ethyl; R(10) is hydrogen, methyl, cycloalkyl having 3, 4, 5, 6, 7 or 8 carbon atoms, CF3, C2F5 or C3F7; n is zero, 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10; R(11) is hydrogen or alkyl having 1, 2, 3, 4, 5 or 6 carbon atoms; or R(10) and R(11) together are a bond, provided n is not smaller than 3; or R(3) together with R(4) is an alkylene chain having 3, 4, 5, 6, 7 or 8 carbon atoms, where one CH2 group of the alkylene chain can be replaced by -O-, -CO-, -S-, -SO-, -SO2- or -NR(12a)-; R(12a) is hydrogen, methyl or ethyl; R(4) is R(13)-CrH2r, R(13) is H, CF3, C2F5, C3F7, cycloalkyl having 3, 4, 5, 6, 7 or 8 carbon atoms, -NR(15)R(16), -OR(17), -COOR(17), phenyl or an N-containing heterocycle having 1, 2, 3, 4, 5, 6, 7, 8 or 9 carbon atoms, where phenyl and the N-containing heterocycle are unsubstituted or substituted by 1 or 2 substituents selected from the group consisting of F, Cl, Br, I, CF3, NO2, CN, NH2, OH, methyl, ethyl, methoxy, dimethylamino, sulfamoyl, methylsufonyl and methylsulfonylamino; R(15) and R(16) independently of one another are hydrogen or alkyl having 1, 2, 3 or 4 carbon atoms; or R(15) and R(16) together are a chain of 4 or 5 methylene groups, of which one CH2 group can be replaced by -O-, -S-, -NH-, N(CH3)- or -N(benzyl)-; R(17) is hydrogen, alkyl having 1, 2 or 3 carbon atoms, 2139 ה' בחשון התשס" ד - October 31, 2003 r is zero, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20; at least one of the subsitutents R(5), R(6), R(7) and R(8) is -Y-CsH2s-R(18), thienyl, furyl or an N-containing heterocycle having 1, 2, 3, 4, 5, 6, 7, 8 or 9 carbon atoms, where thienyl, furyl and the N-containing heterocycle are unsubstituted or substituted by 1 or 2 subsituents selected from the group consisting of F, Cl, Br, I, CF3, NO2, CN, NH2, OH, methyl, ethyl, methoxy, methylamino, dimethylamino, ethylamino, diethylamino, sulfamoyl, methylsulfonyl and methylsulfonylamino; Y is -O-, -CO-, -O-CO-, -S-, -SO-, -SO2-, -SO2-O-, -SO2NR(12d)-, NR(12d)- or -CONR(12d)-, where the linkage to the benzene nucleus in each case takes place via the left atom; R(12d) is hydrogen, methyl or ethyl; s is 1, 2, 3, 4, 5 or 6; R(18) is substituted phenyl which carries one or two substituents selected from the group consisting of NO2, CN, NH2, N(methyl)2, OH, ethyl, -COOH, -COO methyl, -COOethyl, -CONH2, -CON(methyl)2; or R(18) is a substituted N-containing heterocycle having 1, 2, 3, 4, 5, 6, 7, 8 or 9 carbon atoms, which carries one or 2 substituents selected from the group consisting of F, Cl, Br, I, CF3, NO2, CN, NH2, OH, methyl, ethyl, methoxy, dimethyl- amino, sulfamoyl, methylsulfonyl and methylsulfonylamino; or R(18) is -OR(19), -SO2R(19), -NR(19)R(20), -CONR(19)R(20); R(19) and R(20) independently of one another are CtH2t-R(21); t is zero, 1, 2, 3, 4, 5 or 6; R(21) is hydrogen, CF3, C2F5, C3F7, cycloalkyl having 3, 4, 5, 6, 7 or 8 carbon atoms, NR(22)R(23), -OR(24), phenyl, thienyl or an N-containing heterocycle having 1, 2, 3, 4, 5, 6, 7, 8 or 9 carbon atoms, where phenyl, thienyl and the N-containing heterocycle are unsubstituted or substituted by 1 or 2 substituents selected from the group consisting of F, Cl, Br, I, CF3, NO2, CN, NH2, OH, methyl, ethyl, methoxy, dimethylamino, sulfamoyl, methylsufonyl and methylsulfonylamino; R(22) and R(23) independently of one another are hydrogen, alkyl having 1, 2 or 3 carbon atoms; or R(22) and R(23) together are a chain of 4 or 5 methylene groups, of which one CH2 group can be replaced by -O-, -S-, -NH-, -N(CH3)- or -N(benzyl)-; R(24) is hydrogen, alkyl having 1, 2 or 3 carbon atoms; and the other substituents R(5), R(6), R(7) and R(8) in each case, which are still not assigned by the definition given above, independently of one another are hydrogen, F, Cl, Br, I, alkyl having 1, 2, 3, 4, or 5 carbon atoms, cycloalkyl having 3, 4, 5, 6, 7 or 8 carbon atoms, CN, CF3, NO2, OR(12e) or NR(12e) R (12f); R(12e) and R(12f) independently of one another are hydrogen or alkyl having 1, 2, 3 or 4 carbon atoms; R(9) is hydrogen, OR(12g) or OCOR(12g); R(12g) is hydrogen or alkyl having 1, 2 or 3 carbon atoms; B is hydrogen; or R(9) and B together are a bond; or their physiologically tolerable salts.
机译:其中下式的化合物:R(1)和R(2)彼此独立地是氢,CF3,C2F5,C3F7,具有1-6个碳原子的烷基或苯基,其被1个或2个取代基取代或未取代,选自F,Cl,Br,I,CF3,NO2,CN,NH2,OH,甲基,乙基,甲氧基,21382'חש'ו2003התשס“-2003年10月31日二甲氨基,氨磺酰基,甲基磺酰基和甲基磺酰基氨基;或R(1)和R(2)一起为具有2、3、4、5、6、7、8、9或10个碳原子的亚烷基链; R(3)为R(10)-CnH2n-NR (11)-或R(10)-CnH2n-,其中基团CnH2n中的一个CH2基团可被-O-,-CO-,-S-,-SO-,-SO2-或-NR(12a)取代-; R(12a)为氢,甲基或乙基; R(10)为氢,甲基,具有3、4、5、6、7或8个碳原子的环烷基,CF3,C2F5或C3F7; n为零,1 2、3、4、5、6、7、8、9或10; R(11)是氢或具有1,2、3、4、5或6个碳原子的烷基;或R(10)和R(11 )在一起是一个键,前提是n不是sm大于3或R(3)与R(4)一起是具有3、4、5、6、7或8个碳原子的亚烷基链,其中亚烷基链的一个CH 2基团可被-O-,-CO-取代, -S-,-SO-,-SO2-或-NR(12a)-; R(12a)为氢,甲基或乙基; R(4)是R(13)-CrH2r,R(13)是H,CF3,C2F5,C3F7,具有3、4、5、6、7或8个碳原子的环烷基,-NR(15)R(16) ,-OR(17),-COOR(17),苯基或具有1,2,3,4,5,6,7,8或9个碳原子的含N杂环,其中苯基和含N杂环为未取代或被1或2个选自F,Cl,Br,I,CF 3,NO 2,CN,NH 2,OH,甲基,乙基,甲氧基,二甲氨基,氨磺酰基,甲基磺酰氨基和甲基磺酰基氨基的取代基取代; R(15)和R(16)彼此独立地是氢或具有1、2、3或4个碳原子的烷基;或R(15)和R(16)一起是4或5个亚甲基的链,其中一个CH2基团可被-O-,-S-,-NH-,N(CH3)-或-N取代(苄基)-; R(17)是氢,碳原子数为1、2或3的烷基,2139-2003年10月31日r为零,1、2、3、4、5、6、7、8、9 ,10、11、12、13、14、15、16、17、18、19或20;取代基R(5),R(6),R(7)和R(8)中的至少一个是- Y-CsH 2s -R(18),噻吩基,呋喃基或具有1、2、3、4、5、6、7、8或9个碳原子的含氮杂环,其中噻吩基,呋喃基和含N杂环为未取代的或被1或2个选自F,Cl,Br,I,CF 3,NO 2,CN,NH 2,OH,甲基,乙基,甲氧基,甲氨基,二甲氨基,乙氨基,二乙氨基,氨磺酰基,甲磺酰基和甲基磺酰氨基; Y为-O-,-CO-,-O-CO-,-S-,-SO-,-SO2-,-SO2-O-,-SO2NR(12d)-,NR(12d)-或- CONR(12d)-,其中分别通过左原子与苯核连接; R(12d)为氢,甲基或乙基; s为1、2、3、4、5或6; R( 18)是带有一个或两个选自gro的取代基的取代苯基由NO2,CN,NH2,N(甲基)2,OH,乙基,-COOH,-COO甲基,-COO乙基,-CONH2,-CON(甲基)2组成;或R(18)是具有1、2、3、4、5、6、7、8或9个碳原子的取代的含N杂环,其带有一个或2个选自F,Cl,Br的取代基,I,CF 3,NO 2,CN,NH 2,OH,甲基,乙基,甲氧基,二甲基-氨基,氨磺酰基,甲基磺酰基和甲基磺酰基氨基;或R(18)为-OR(19),-SO2R(19),-NR(19)R(20),-CONR(19)R(20); R(19)和R(20)彼此独立地是CtH 2 t-R(21); t为零,1、2、3、4、5或6; R(21)是氢,CF3,C2F5,C3F7,具有3、4、5、6、7或8个碳原子的环烷基,NR(22)R(23),-OR(24),苯基,噻吩基或N具有1、2、3、4、5、6、7、8或9个碳原子的含杂环,其中苯基,噻吩基和含N杂环未被取代或被1个或2个选自F的取代基取代,Cl,Br,I,CF 3,NO 2,CN,NH 2,OH,甲基,乙基,甲氧基,二甲基氨基,氨磺酰基,甲基磺酰基和甲基磺酰基氨基; R(22)和R(23)彼此独立地是氢,具有1、2或3个碳原子的烷基;或R(22)和R(23)一起是4或5个亚甲基的链,其中一个CH2基团可被-O-,-S-,-NH-,-N(CH3)-或-取代N(苄基)-; R(24)是氢,具有1、2或3个碳原子的烷基;以及在每种情况下仍未被上述定义赋予的其他取代基R(5),R(6),R(7)和R(8)彼此独立地为氢,F,Cl,Br ,I,具有1、2、3、4或5个碳原子的烷基,具有3、4、5、6、7或8个碳原子的环烷基,CN,CF3,NO2,OR(12e)或NR(12e)R (12f); R(12e)和R(12f)彼此独立地是氢或具有1、2、3或4个碳原子的烷基; R(9)是氢,OR(12g)或OCOR(12g); R(12g)是氢或具有1、2或3个碳原子的烷基; B是氢;或R(9)与B共同为键;或其生理上可接受的盐。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号